Some PROCEPT BioRobotics Corporation (NASDAQ:PRCT) shareholders may be a little concerned to see that the President, Reza Zadno, recently sold a substantial US$976k worth of stock at a price of US$61.31 per share. That sale reduced their total holding by 25% which is hardly insignificant, but far from the worst we've seen.

PROCEPT BioRobotics Insider Transactions Over The Last Year

The Independent Director, Antal Desai, made the biggest insider sale in the last 12 months. That single transaction was for US$9.0m worth of shares at a price of US$97.59 each. While we don't usually like to see insider selling, it's more concerning if the sales take place at a lower price. The silver lining is that this sell-down took place above the latest price (US$56.03). So it may not shed much light on insider confidence at current levels.

In the last year PROCEPT BioRobotics insiders didn't buy any company stock. The chart below shows insider transactions (by companies and individuals) over the last year. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

I will like PROCEPT BioRobotics better if I see some big insider buys. While we wait, check out this free list of undervalued and small cap stocks with considerable, recent, insider buying.

Insider Ownership

For a common shareholder, it is worth checking how many shares are held by company insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. It appears that PROCEPT BioRobotics insiders own 2.6% of the company, worth about US$83m. While this is a strong but not outstanding level of insider ownership, it's enough to indicate some alignment between management and smaller shareholders.

So What Do The PROCEPT BioRobotics Insider Transactions Indicate?

Insiders haven't bought PROCEPT BioRobotics stock in the last three months, but there was some selling. And there weren't any purchases to give us comfort, over the last year. Insiders own shares, but we're still pretty cautious, given the history of sales. We're in no rush to buy! So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing. For example - PROCEPT BioRobotics has 1 warning sign we think you should be aware of.

Of course PROCEPT BioRobotics may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.